Purpose: Chromatic variations across different copies and different editions of pseudoisochromatic tests and violation of underlying principles of construction for individual plates can influence test results. Methods: We analysed the colorimetric characteristics of three different editions of Velhagen-Broschmann pseudoisochromatic plates (30th edition printed in 1995, 31st edition printed in 1997, 32nd edition printed in 2000). One hundred and twelve coloured dots of 18 plates were chosen from each edition. We measured RGB and CIE XYZ values using a spectrophotometer. Differences in lightness and chromaticity between corresponding dots of different editions were analysed in terms of ΔL* and Δu’v’, respectively. For each plate deviations from dichromatic confusion lines were analysed. Furthermore, we determined the relative luminance of a target compared to its background in terms of the Weber contrast. Results: The mean ΔL* across editions was 2.05 (±1.4) and the mean Δu’v’ was 0.0078 (±0.0029). For two plates the deviations of targets from dichromatic confusion lines exceeded suggested values. For a number of plates, the lightness contrast between the symbol and its background was high. Comparison with psychophysical data showed that these colour plates are easily detectable by colour-deficient observers. Conclusions: Lightness and chromatic variation across the three editions was moderate except for a small number of plates perhaps due to inaccuracies in the printing process. The design of several plates should be revised according to standard principles of construction of colour deficiency tests.

Keywords:
Colour vision, Colour vision testing, Pseudoisochromatic test, Colorimetric analysis
1.
Heinsius E: Die Farbsinnstörungen und ihre Prüfung in der Praxis. Stuttgart, Enke, 1973.
2.
Hyon JY, Lee JH, Wee WR: Shift of colorimetric values in Ishihara pseudoisochromatic plates with plate aging. Korean J Ophthalmol 2005;19:145–148.
3.
Dain SJ: Clinical colour vision tests. Clin Exp Optom 2004;87:276–293.
4.
Dain SJ, Gray S, Tran L: Colorimetric analysis and performance assessment of the Hahn new pseudoisochromatic colour vision test. Color Res Appl 1998;23:69–77.
5.
Lakowski R: Colorimetric and photometric data for the 10th edition of the Ishihara plates. Br J Physiol Opt 1965;22:195–207.
6.
Lakowski R: Object analysis of the Stilling tables. Mod Probl Ophthalmol 1976;17:166–171.
7.
Honson VJ, Dain SJ: Performance of the standard pseudoisochromatic plate test. Am J Optom Physiol Opt 1988;65:561–570.
8.
Lee DY, Honson M: Chromatic variation of Ishihara diagnostic plates. Color Res Appl 2003;28:267–276.
9.
Dain SJ: Colorimetric analysis of four editions of the Hardy-Rand-Rittler pseudoisochromatic tests. Vis Neurosci 2004;21:437–443.
10.
Kuchenbecker J, Wecke T, Wiermer R, Röhl FW, Lindner H, Behrens-Baumann W: Untersuchungen des Farbsinns mittels eines Web-basierten Farbsehtests. Ophthalmologe 2004;101:278–284.
11.
Kuchenbecker J, Röhl FW, Wesselburg A, Bernarding J, Behrens-Baumann W: Untersuchungen zur Validität eines Web-basierten Farbsehtest für Screeninguntersuchungen des Farbensehens. Ophthalmologe 2007;104:47–53.
12.
Lakowski R, Oliver K: Discrimination steps of dichromats. Report from the Visual Laboratory, Psychology Department, UBC, Vancouver, 1979.
13.
Smith VC, Pokorny J: Spectral sensitivity of the foveal cone photopigments between 400 and 500 nm. Vision Res 1975;15:161–171.
14.
Report of Working Group 41 CoV, Assembly of Behavioral and Social Sciences, National Research Council: Procedures for Testing Colour Vision. Washington, National Academy Press, 1981.
15.
Koffka K: Principles of Gestalt Psychology. New York, Harcourt-Brace, 1935.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.